Applied Biometrics, Inc. (ABIO.PK)

Applied Biometrics, Inc. ceased its ongoing business operations in August 2000 because it determined that it would be unable to complete the development of its primary product, the Basis Cardiac Output Monitor and RealFlow Cardiac Output Probe (collectively, the Basis System), for market and sale. Prior to deciding to cease its business operations, the Company was developing a system designed to measure cardiac output (CO) on a continuous and real-time basis during and after cardiac surgery. The Basis System was designed for use on a broad range of aortic diameters in both adults and children. By using ultrasound to monitor CO directly from the ascending aorta, the Basis System was expected to provide real-time accuracy. In contrast to conventional CO techniques, the Basis System was designed to directly measure the patient's aortic diameter and blood velocity 44 times each second for a true, real-time view of cardiac output.

ABIO was a medical device company engaged in the research and development of advanced cardiovascular and hemodynamic diagnostic and monitoring systems. In 8/00, ABIO announced that it had terminated all business operations. For the 9 months ended 9/30/00, the Company reported no revenues. Net loss rose 39% to $2.4M. Results reflect increased non-compensation charges and increased research and development expenses.